| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3348 |
| Trial ID | NCT05744037 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Co-treatment | Ibrutinib |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Clinical Study of the Safety and Efficacy of the R/R B-NHL Regimen With BTK Inhibitor+Anti-CD19 CAR-T Cells |
| Year | 2023 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Other ID(s) | XYFY2022-KL365-02 |
| Cohort 1 | |||||||||
|
|||||||||